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Genus-specific kinetoplast-DNA PCR and parasite culture  
for the diagnosis of localised cutaneous leishmaniasis:  
applications for clinical trials under field conditions in Brazil
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The positivities of two methods for the diagnosis of localised cutaneous leishmaniasis (CL) were estimated in 280 
patients enrolled in a clinical trial. The trial was conducted in an endemic area of Leishmania (Viannia) braziliensis 
and trial participants were patients with skin ulcers and positive leishmanin skin tests. Patients underwent aspira-
tive skin punctures of the ulcerated lesions and lymph nodes for in vitro cultures, which were processed under field 
conditions at the local health centre. Skin lesion biopsies were tested at a reference laboratory using kinetoplastid 
DNA (kDNA)-PCR to detect DNA. The median time required to obtain a positive culture from the skin samples was 
seven days and the contamination rate of the samples was 1.8%. The positivities of the cultures from skin lesions, 
kDNA-PCR and the combination of the two methods were 78.2% (95% CI: 73-82.6%), 89.3% (95% CI: 85.1-92.4%) 
and 97.1% (95% CI: 94.5-98.5%). We conclude that parasite culture is a feasible method for the detection of Leish-
mania in field conditions and that the combination of culture and PCR has a potential role for the diagnosis of CL 
in candidates for clinical trials.
Key words: cutaneous leishmaniasis - Leishmania braziliensis - polymerase chain reaction - isolation and purification - clinical trials
Financial support: Secretaria de Vigilância em Saúde do Ministério 
da Saúde, FAPDF (PRONEX/FAPDF 193.000-114/2004), FINATEC, 
PIBIC/CNPq/MCT, CAPES/MEC
+ Corresponding author: gromero@unb.br
Received 18 May 2009
Accepted 2 September 2009
Cutaneous leishmaniasis (CL) is caused by protozoa 
belonging to the genus Leishmania and the disease is a 
widespread public health problem that mainly affects 
low-income populations (Grimaldi Jr & Tesh 1993, 
Murray et al. 2005, Alvar et al. 2006). Between 1985-
2005, the mean annual number of autochthonous cases 
was 28,568, as reported to the Brazilian surveillance 
system; this corresponds to a mean detection coeffi-
cient of 18.5 cases/100,000 inhabitants. The highest in-
cidence rate was observed in the North and Northeast 
Regions of Brazil, with most of the cases registered in 
the states of Maranhão, Ceará and Bahia (BA). The 
cases registered in BA were detected in the Southern 
Region, where the Corte de Pedra Health Centre is lo-
cated. In that region, most cases of leishmaniasis are 
caused by Leishmania (Viannia) braziliensis (Rosa et 
al. 1988, Romero et al. 2001c).
It is possible to observe relevant differences in clini-
cal presentation, diagnostic assay sensitivity and re-
sponse to specific therapeutics based on the species of 
Leishmania causing the infection (Romero et al. 2001 
a, c, Arévalo et al. 2007). Parasitological tests, includ-
ing the direct observation of amastigotes in scrapings 
from skin lesions, cultures and the inoculation of tis-
sue samples into hamsters, have usually demonstrated 
low sensitivity for the diagnosis of L. (V.) braziliensis 
infections. This problem was not observed to the same 
magnitude in infections caused by Leishmania (Vian-
nia) guyanensis (Romero et al. 2001c). The main disad-
vantages related to conventional parasitological methods 
include the need for qualified technicians to perform 
the collection, preparation, preservation and observa-
tion of the samples under field conditions, as well as 
in reference laboratories. Furthermore, cultures have 
the additional disadvantage of potential contamination 
with fungi or bacteria, which has been associated with 
prolonged observation (Cuba Cuba et al. 1986a, b). In 
recent years, the collection method has been optimised 
to reduce the problem of contamination and to increase 
the sensitivity of the diagnostic methods (Marzochi et 
al. 1993, Romero et al. 1999a, b). Recently, the use of 
molecular diagnostic tools such as PCR assays specific 
to different DNA targets has increased (Marques et al. 
2001, Safaei et al. 2002, Schallig & Oskam 2002, Wei-
gle et al. 2002). The amplification of the conserved se-
quences found in the minicircles of kinetoplastid DNA 
(kDNA) of Leishmania using PCR is currently one of 
the most common and available techniques (Pirmez et 
al. 1999, Bensoussan et al. 2006).
The lack of sensitivity and specificity of the diagnostic 
methods that can currently be used in rural areas poses 
a large challenge to conducting clinical trials with pa-
tients affected by leishmaniasis in these areas. Although 
parasite culture has been considered by some authors 
(Reithinger et al. 2007) to be the gold standard due to its 
high specificity, the problem of its low sensitivity remains 
unresolved (Murray et al. 2005, Tojal da Silva et al. 2006). 
In the absence of a true gold standard diagnostic assay 
for CL, it is likely that a combination of disease-defining 
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characteristics more accurately represents the true disease 
status (Coggon et al. 2005). This approach was used in 
the present paper to establish the positivity of the methods 
under evaluation using a case definition composed of skin 
ulcers considered suspicious of being caused by leishma-
niasis plus a positive leishmanin skin test.
The present paper was undertaken to estimate the 
positivity of in vitro cultures of samples obtained through 
aspirative punctures from the cutaneous ulcer borders of 
skin lesions. These biopsies were conducted in a rural 
health centre and PCR was performed on the samples at 
a reference laboratory to detect Leishmania DNA using 
kDNA-PCR for the diagnosis of localised CL.
PATIENTS AND METHODS
Study type and patients - This study examined the 
accuracy of two diagnostic tests for leishmaniasis and 
was nested in a clinical trial designed to evaluate the ef-
fectiveness and safety of low doses of pentavalent anti-
monials for the treatment of CL caused by L. (V.) brazi- 
liensis (ClinicalTrials.gov NCT00317980). Patients were 
considered as candidates if they presented with skin ul-
cers suspicious of leishmaniasis (painless ulcerated le-
sions with raised borders and granulose bottoms) and a 
positive leishmanin skin test. All of the patients in the 
study were treated for leishmaniasis at the local health 
centre located at Corte de Pedra District, Presidente Tan-
credo Neves municipality, BA, Brazil, between January 
2006-January 2007. Two hundred-eighty patients were 
enrolled in this study. The trial included male and fe-
male patients aged 7-50 years with up to nine ulcerated 
cutaneous lesions, a positive leishmanin skin test and not 
more than 20 weeks of disease evolution.
Leishmanin skin test - The skin test was performed 
with an antigen prepared at the Immunology Service of 
the Federal University of Bahia, Brazil, as previously 
described (Reed et al. 1986). Briefly, 0.1 mL of soluble 
components of Leishmania (Leishmania) amazonensis 
promastigotes, MHOM/BR/1986/BA125 strain, con-
taining 250 µg/mL protein were injected intradermally 
on the volar surface of the left forearm and the reaction 
was measured after 48-72 h using the standard proce-
dure (Sokal 1975). Diameters of induration greater than 
or equal to 5 mm were considered positive.
Culture medium production and transport conditions 
- The culture medium was prepared in the Leishmaniasis 
Laboratory of the Tropical Medicine Unit at the Universi-
ty of Brasilia using blood agar base, code 0045-17, pH 6.8 
(DIFCO Ltd, Brazil) and 15% defibrinated rabbit blood 
with 100 μg/mL gentamicin (Garamicina®, Schering-
Plough, Rio de Janeiro, Brazil). The tubes containing the 
culture medium were transported by air from Brasilia to 
the capital of BA, on a flight of approximately 1 h and 15 
min duration and they were then transported by car to the 
Corte de Pedra District, which is approximately a 4 h trip. 
The transportation temperature was between 2-8°C.
Culture procedures - The procedures were conduct-
ed after local cleansing of the site with 0.9% sodium 
chloride and then a solution with 1% of active iodine. 
The biopsies were performed under local anaesthesia 
induced with 2% lidocaine without a vasoconstrictor, 
according to the vacuum aspiration technique previ-
ously reported (Romero et al. 1999b). Before the aspira-
tive procedure, 0.2 mL of 0.9% saline solution plus 100 
μg/mL gentamicin (Garamicina®, Schering-Plough, Rio 
de Janeiro, Brazil) were added to the solid medium and 
the vacuum was subsequently restored using a 20 mL 
syringe. Three aspirative punctures from the elevated 
border of the most recent onset cutaneous lesion and 
three aspirative punctures from enlarged satellite lymph 
nodes, if present, were taken from each patient. The 
lymph node aspiration was performed for patients with 
lymph nodes larger than 3 cm in diameter. The aspirated 
material of each puncture was inoculated in separated 
culture tubes. The cultures were kept in the rural health 
centre inside of a glass closet in an air-conditioned room 
with the temperature maintained between 22-24°C. Ex-
amination of the cultures was performed every 72-96 h 
using a Carl Zeiss Jena inverted microscope (Germany). 
Cultures were later transported to the Brasilia reference 
laboratory for quality control after cultures turned posi-
tive during the observation period or after four weeks of 
observation of negative cultures.
kDNA-PCR - Immediately after the aspirative punc-
tures, a 4 mm sterile punch biopsy was performed. After 
the removal of excess blood with filter paper, the biopsy 
fragment was placed inside a 2 mL dry polypropylene 
tube and maintained at -20°C in the endemic area until 
it was transported to the reference laboratory in Brasilia. 
All samples were transported to Brasilia at the end of the 
enrolment period. DNA extraction was performed us-
ing the commercial illustra tissue & cells genomic Prep 
Mini Spin KitTM (USA) following the manufacturer’s 
recommendations. Three primers were used to amplify 
the conserved region of 120 base pairs of the minicircle 
DNA, one forward: 5´GGG GAG GGG CGT TCT GCG 
AA 3’ (MW = 6602.0 µg/µmol) and two backward: 
5’CCG CCC CTA TTT TAC ACC AAC CCC 3’ (MW = 
7504.8 µg/µmol) and 5’GGC CCA CTA TAT TAC ACC 
AAC CCC 3’ (MW = 7577.8 µg/µmol). The two back-
ward primers were aimed to accommodate sequence 
variation in the minicircle population. These primers 
have been extensively used in Brazil for genus-specific 
diagnosis of Leishmania infection (Degrave et al. 1994a, 
b). Authors have described those primers with different 
names and notations (Pirmez et al. 1999, Romero et al. 
2001a, 2009, Volpini et al. 2004, De Assis et al. 2008, 
Luz et al. 2009). The amplification procedure was per-
formed in a Perkin Elmer GeneAmp PCR System 2400 
thermocycler (The Perkin Elmer Corporation, Norwalk, 
CT, USA). Briefly, reaction mixtures were prepared in 
a 10 μL volume using 1 μL of DNA sample in 10 mM 
Tris-HCl pH 8.6, 0.25 units of Taq DNA polymerase 
(Promega, Madison, WI, USA), 50 mM KCl pH 8.3, 
1.5 mM MgCl2 and 50 μM of each dNTP. The primer 
concentration in the mixture was 1.2 μM (forward) and 
0.6 μM (each backward). Thirty-nine amplification cy-
cles were undertaken using a temperature of 95°C for 
denaturation, 66°C for annealing and 72°C for exten-
sion, with 30 s for each step. Five minutes of initial de-
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naturation and 5 min final extension were applied. All of 
the reactions were performed with appropriate positive 
and negative controls. The positive control was prepared 
with DNA extracted from a log phase culture of pro-
mastigotes of L. (V.) braziliensis MHOM/BR/75/M2904 
with an analytic sensitivity of at least one parasite. The 
amplified products were then analysed by 8% polyacryl-
amide gel electrophoresis performed in 1X TBE buffer 
at 100 volts (Sambrook et al. 2001) and subsequent silver 
staining (Bassam et al. 1991).
Statistical analysis - The analysis was performed 
using SPSS 16.0 for Windows (SPSS Inc, Chicago, IL, 
USA). The proportions of positive results were cal-
culated for each diagnostic technique along with their 
respective 95% confidence intervals (95% CI) and pro-
portions were compared using a Chi-squared test. Con-
tinuous, normally distributed data were stated as means 
plus one standard deviation. Continuous data without a 
normal distribution were described as medians and the 
25th (Q25) and 75th (Q75) percentiles, respectively, were 
noted. Continuous variables with a normal distribution 
were compared using the Student’s t-test; otherwise, the 
Mann-Whitney U test was applied. P values < 0.05 were 
considered statistically significant.
Ethics - The clinical trial was approved by the Ethi-
cal Committee of the Faculty of Medicine of the Univer-
sity of Brasilia (007/2004). The research protocol was 
conducted in agreement with the Helsinki Declaration 
and Resolutions 196/1996 and 251/1997 of the National 
Health Council of the Brazilian Ministry of Health. All 
diagnostic procedures in the present study are recogn-
ised by the Brazilian Ministry of Health as valid alterna-
tives for CL diagnosis. All patients or their legal guard-
ians signed the informed consent paperwork before any 
procedures were performed.
RESULTS
In total, 280 patients were included and 67.1% were 
males. The median age was 21 years (Q25-Q75: 15-31), the 
median disease duration was 30 days (Q25-Q75: 28-60), 
33% of the patients had lesions on their legs, 63% had 
only one cutaneous lesion and 94.6% of the patients pre-
sented with enlarged lymph nodes that were detected at 
the time of clinical diagnosis.
Of the 280 patients, 279 each received three aspira-
tive punctures of the ulcer borders of their cutaneous le-
sions; the aspirative punctures subsequently underwent 
parasite culture. The remaining patient only received one 
aspirative puncture, which was then cultured. Sixty pa-
tients were willing to provide aspirative cultures of their 
satellite lymph nodes. Consequently, 838 culture tubes 
inoculated with skin ulcer samples and 180 culture tubes 
inoculated with lymph node samples were observed as 
previously described.
The positivity of the culture tubes inoculated with 
skin samples was 65.8% (551/838): 190 of 280 tubes 
(67.9%) inoculated with the first aspirative puncture 
sample, 186 of 279 tubes (66.7%) inoculated with the 
second sample and 175 of 279 tubes (62.7%) inoculated 
with the third sample were found to be positive. The me-
dian time required to obtain a positive culture tube from 
a skin sample was seven days (Q25-Q75: 5-10) (Figure), 
with the time required ranging from 1-31 days. Fungal 
contamination was found in 1.8% of skin culture tubes.
The overall positivity of the culture tubes inoculated 
with the lymph node samples was 36.6% (66/180): 20 of 
60 (33.3%) inoculated with the first aspirative puncture 
sample, 25 of 60 (41.7%) inoculated with the second sam-
ple and 21 of 60 tubes (35%) inoculated with the third 
sample were found to be positive. The median time re-
quired to obtain a positive culture tube after inoculation 
with the lymph node samples was seven days (Q25-Q75: 
6-10; range 3-27 days) (Figure). Fungal contamination 
was found in 2.2% of lymph node culture tubes. Of note, 
two patients who presented with negative skin cultures 
were found to have positive lymph node cultures.
Distribution of the number of days to obtain a positive culture around the 
median (horizontal line) depending on the sample source in patients with 
cutaneous leishmaniasis. Boxes extend from 25-75th percentiles. Whis-
kers extend to the largest and smallest observed values in the distribution 
having the limits which correspond to 1.5 times the box length around the 
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Of patients who had positive skin cultures collected, 
65% (143/219) had positive results in all three culture 
tubes inoculated with skin samples, 21% (46/219) had 
positive results in two tubes and 13.7% (30/219) had only 
one positive sample. Conversely, 14 of the 27 patients with 
positive cultures from lymph node punctures had positive 
results from all three samples, 11 patients had two positive 
samples and two patients had only one positive sample.
The overall positivity of the skin cultures, lymph 
node cultures and both types of cultures combined, 
considering the patient as the unit for this analysis, is 
shown in Table I.
Positivity of the kDNA-PCR was 89.3%. Combin-
ing both diagnostic methods increased the overall posi-
tivity to 97.1% (Table I). Overall, eight patients had no 
demonstration of the presence of Leishmania by the two 
studied methods.
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Using skin lesion culture as the gold standard, the 
sensitivity of the kDNA-PCR assay, evaluated using the 
data of the 219 patients with positive cultures, was 90% 
(95% CI: 85.4-93.4%). The agreement between the cul-
ture and PCR results is demonstrated in Table II.
DISCUSSION
Conducting clinical trials in health centres located 
in rural areas where leishmaniasis is endemic repre-
sents a challenge for researchers because of the diffi-
culty associated with confirming the diagnosis. Ide-
ally, methods to confirm the diagnosis should be easy 
to use and capable of producing rapid results, allowing 
the crucial decision of patient inclusion in a trial to be 
made. To maintain the scientific rigor of the research, 
it is necessary to obtain parasitological confirmation of 
each case to maintain high internal validity of the study 
and to avoid deleterious exposure of patients without 
leishmaniasis to the drugs under evaluation. The pres-
ent paper was not intended to validate the diagnostic 
methods but to demonstrate that a combination of para-
site culture available under field conditions and mo-
lecular tools applied in samples sent to a reference lab 
could be a useful and viable solution for parasitological 
diagnosis of human cases in clinical trials.
Most cases of leishmaniasis in the endemic area of 
Corte de Pedra are caused by L. (V.) braziliensis. There-
fore, it offers an ideal setting for clinical research and the 
evaluation of diagnostic tests for the diseases caused by 
this species without the confusion derived from the sym-
patric circulation of other species of Leishmania (Rosa et 
al. 1988, Romero et al. 2001c, 2009). Early studies con-
ducted in the areas of Três Braços and Corte de Pedra 
performed cultures from skin lesions, obtained positivity 
rates of 15.3-30.8% and had a contamination rate as high 
as 27.5%. Positivity increased to 51% when three cul-
tures were obtained from each patient and each aspirate 
came from three different points along the ulcer border of 
the same lesion (Cuba Cuba et al. 1986a). We suggested 
in two previous reports with a small sample of patients 
(Romero et al. 1999a, b) that the combined approach of 
aspirative punctures of skin ulcers and lymph nodes pro-
duces better results. The present research, which evalu-
ated a substantially higher number of patients, did not 
confirm the findings of our previous reports, but the low 
receptivity of the patients allowing the lymph node punc-
ture. The overall skin culture and PCR yield was simi-
lar to those reported by other authors (Luz et al. 2009), 
which confirmed the reproducibility of this method. The 
low contamination rate was also reproduced in the pres-
ent study with a larger number of observations.
It is known that the positivity of parasitological diag-
nostic methods is directly associated with the duration 
of the presence of the lesion. In our research, the median 
duration of cutaneous disease was 30 days, which might 
have contributed to the performance of the culture. The 
modification of culture methods to accelerate the time 
necessary to obtain positive results has been reported, 
with sensitivities ranging from 83-97% in Turkey (Allah-
verdiyev et al. 2004) and from 71.7-84.7% in Peru, where 
the investigators used microcultures and minicultures in 
polypropylene tubes (Boggild et al. 2007, 2008).
Some molecular methods have elevated specificity 
for diagnosing leishmaniasis and have the advantage of 
identification of parasite species, strains and even clones. 
However, those more specific methods are the least sen-
sitive and work better when applied for the identification 
of isolated parasites obtained from cultures (Schallig & 
TABLE I
Positivity of diagnostic methods for cutaneous leishmaniasis in patients with clinical suspected ulcers  
and a positive leishmanin skin test
Method





Skin culture (any culture tube) 219/280 78.2 73.0-82.6
Lymph node culture (any culture tube) 27/60 45.0 33.1-57.5
Skin or lymph node culture (any culture tube) 221/280 78.9 73.8-83.3
Kinetoplastid DNA-PCR 250/280 89.3 85.1-92.4
Skin or lymph node culture or kinetoplastid DNA-PCR 272/280 97.1 94.5-98.5
CI: confidence interval.
TABLE II
Comparison of the results obtained with cultures from skin 
ulcers and the kinetoplastid DNA-PCR (kDNA-PCR) assay in 
patients with cutaneous ulcers suspected of leishmaniasis and 
a positive leishmanin skin test
Result of the kDNA-PCR







Positive 197 (90) 53 (86.9) 250
Negative 22 (10) 8 (13.1) 30
Total 219 (100) 61 (100) 280
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Oskam 2002, Bensoussan et al. 2006, Tojal da Silva et al. 
2006). The use of PCR to amplify the conserved 120-bp 
region of kDNA has been shown to be the most sensi-
tive approach for routine diagnostic use (Tojal da Silva 
et al. 2006). The sensitivity is higher than other assays 
because it can accurately detect cases of leishmaniasis 
when the identification of parasite species is not essen-
tial. The combination of different molecular approaches 
allows appropriate parasite identification in areas where 
sympatric circulation of several Leishmania species is 
a problem (Bensoussan et al. 2006, Tojal da Silva et al. 
2006). Our study demonstrated a PCR positivity of 89%, 
which is lower than has been described in other areas 
(Pirmez et al. 1999, Gomes et al. 2008, Reis et al. 2008). 
However, our results are consistent with a previous study 
in the same area that reported a positivity of 88.3% for 
PCR performed with DNA obtained from fresh-frozen 
lesion biopsies and positivities of 87% and 85.7% for PCR 
performed with DNA obtained from biopsy imprints on 
filter paper in two independent laboratories (Romero 
et al. 2009). This consistency between results obtained 
during different periods allows us to suggest that in the 
area studied, the two diagnostic methods that were per-
formed in the present trial should be combined for the 
diagnostic confirmation of Leishmania infection.
The challenge for the study of the validity of diag-
nostic tests for leishmaniasis is the lack of a gold stan-
dard. Parasite culture has low sensitivity and when used 
as the gold standard, it causes artificially low estimates 
for specificity due to the increase in “false-positive” re-
sults. This was the case in our study, as PCR detected 
86.9% of the culture-negative cases. On the other hand, 
PCR is not a perfect new tool, because it did fail to detect 
Leishmania in 10% of the culture-positive cases.
The observation of cultures in the endemic area, the 
use of methods of sample conservation for performing 
PCR using DNA obtained from imprints on filter paper 
(Marques et al. 2001, Romero et al. 2009) and improve-
ment of fresh biopsy tissue transportation (Castilho et al. 
2003) allow initiatives to develop clinical research under 
field conditions, as these methods do not require sophis-
ticated equipment to obtain an early diagnosis. Sample 
transportation for processing in reference laboratories 
using filter paper or other conservation techniques as-
sociated with the present culture approach will allow 
for the accurate identification of potential candidates for 
clinical trials for the treatment of leishmaniasis.
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